Generic placeholder image

Current Medicinal Chemistry - Anti-Cancer Agents

Editor-in-Chief

ISSN (Print): 1568-0118
ISSN (Online): 1875-5968

Novel Oncogenic Protein Kinase Inhibitors for Cancer Therapy

Author(s): Tomi K. Sawyer

Volume 4, Issue 5, 2004

Page: [449 - 455] Pages: 7

DOI: 10.2174/1568011043352830

Price: $65

Abstract

Small-molecule drug discovery for cancer therapy is making extraordinary progress within the realm of advancing novel oncogenic protein kinase inhibitor lead compounds of significant impact to both basic research and clinical testing. In this perspective, structure- and mechanism-based drug design are highlighted relative to such progress. Also, evolving concepts in novel oncogenic protein kinase inhibitor drug discovery is highlighted relative to therapeutic target selectivity, including the recent identification of oncogenic kinase mutants effecting drug-resistance or enhanced drug susceptibility to small-molecule inhibitors.

Keywords: oncogenic protein kinase, structure-based drug design, mechanism-based drug design, receptor tyrosine kinase, non-receptor tyrosine kinase, non-receptor serine/threonine kinase, atp binding site, protein kinase selectivity, sti-571, bms-354825


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy